CopyMark Law Group
4.9/5
Drawing for HOMEODEL

USPTO serial 79286977

HOMEODEL

Reviewed by CopyMark Law Group

Reg. 6504468Status 700Renewal
Filing date
Status date
Registration date
Oct 5, 2021
Examiner
GARDNER, DAWNA BERYL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HOMEODEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $650

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew A. Homyk

Matthew A. Homyk Blank Rome LLPOne Logan SquarePhiladelphia, PA 19103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Homeopathic supplements; homeopathic medicines; homeopathic anti-inflammatory ointments; homeopathic pharmaceuticals for use in the treatment of allergies, asthma, insomnia, sinus congestion, indigestion, hay fever and motion sickness; homeopathic pharmaceuticals for use in the treatment of dermatitis, dry skin, irritated skin, acne, sunburn, cracked skin, insect bites, minor skin wounds, rashes, warts, blisters, boils, canker sores, cradle cap and scars; homeopathic pharmaceuticals for use in the treatment of gynecological disorders, hot flashes, functional problems associated with menopause, disorders of the digestive system, intestinal diseases, gastroenterological diseases, nausea and urinary functional disorders; homeopathic pharmaceuticals for use in the treatment of anxiety, sleep disorders, nervousness, irritability, nerve pain, apprehensiveness, emotional palpitations and mental fatigue; homeopathic pharmaceuticals for use in the treatment of eye diseases, nose and throat diseases, rhinitis, colds, coughs, gum pain for children, restlessness and irritability; pharmaceutical products for the treatment of allergies, asthma, insomnia, sinus congestion, indigestion, hay fever, motion sickness, dermatitis, dry skin, irritated skin, acne, sunburn, cracked skin, insect bites, minor skin wounds, rashes, warts, blisters, boils, canker sores, cradle cap and scars; pharmaceutical products for the treatment of gynecological disorders, hot flashes, functional problems associated with menopause, disorders of the digestive system, intestinal diseases, gastroenterological diseases, nausea and urinary functional disorders; pharmaceutical products for the treatment of anxiety, sleep disorders, nervousness, irritability, nerve pain, apprehensiveness, emotional palpitations and mental fatigue; pharmaceutical products for the treatment of eye diseases, nose and throat diseases, rhinitis, colds, coughs, gum pain for children, restlessness, and irritabilityACTIVE—
035Retail drug store services and wholesale store services all featuring homeopathic supplements, homeopathic medicines, homeopathic anti-inflammatory ointments, homeopathic pharmaceuticals, pharmaceuticals, balms for pharmaceutical use, decoctions for pharmaceutical use, lotions for pharmaceutical use, pills for pharmaceutical use, therapeutic agents and medicines; online retail store services featuring homeopathic supplements, homeopathic medicines, homeopathic anti-inflammatory ointments, homeopathic pharmaceuticals, pharmaceuticals, balms for pharmaceutical use, decoctions for pharmaceutical use, lotions for pharmaceutical use, pills for pharmaceutical use, therapeutic agents, and medicinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 9, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 10, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 17, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 17, 2022FIMPFINAL DISPOSITION PROCESSED—
Jan 5, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 5, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 20, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 18, 2021GPNXNOTIFICATION PROCESSED BY IB—
Jun 30, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 30, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 30, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 14, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 11, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 22, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 22, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 5, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 25, 2020RFRRREFUSAL PROCESSED BY MPU—
Jul 23, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 22, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2020DOCKASSIGNED TO EXAMINER—
Jun 12, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 8, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 4, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance